Back to top

Genmab A/S (0MGB) Gets a Buy from Barclays

Barclays analyst James Gordon CFA maintained a Buy rating on Genmab A/S today and set a price target of DKK2,500.00. According to TipRanks, Gordon ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Genmab A/S Sponsored ADR (GMAB)